Professor Stephen Till is a consultant in Adult Allergy practising at Guy’s and St Thomas’s Hospital and the London Bridge Hospital. He is also a Senior Lecturer and Consultant at King’s College London.
Professor Till is a known expert in allergic rhinitis, food allergies and immunotherapy/desensitisation for allergic disease. Professor Till qualified as a doctor at University College London. He held a scholarship at the University of Oxford and completed a PhD in Allergy from Imperial College. He underwent five years of specialist training in Allergy at the Royal Brompton and Harefield NHS Trust. At present, he is one of the relatively few consultants listed on the GMC specialist register as an Allergist.
Professor Till combines his medical practice with an interest in research, teaching and the supervision of PhD students. He conducts academic research in the fields of food allergy, immunotherapy and immunology and is author on a range of peer-reviewed publications over a 20 year period. His research had been funded by the National Institute of Health research and the Medical Research Council. In 2009 prof Till was given the World Allergy Organisation Henning Lowenstein Award for his academic research into Allergy.
- Skin Prick Test
- Allergen Desensitisation
- Allergy Blood Tests
- Allergy Shots (Immunotherapy)
- Food Provocation (Challenge) Test
- Angioedema (Swelling)
- Food Allergies
- Urticaria (Hives)
- Allergic Rhinitis (Hayfever)
- Drug Allergies
- Insect or Bee Sting Allergies
Qualifications and training:
- MA (Oxon)
- MB BS
- CCT in Allergy
Winner of the Ernest Foulkes Prize for Medical Research in 2004
Winner of the World Allergy Organisation Henning Lowenstein Award for Research in Allergy in 2009
Winner of the ‘Joint working between Allied Health Professionals and Healthcare scientists’ category, at the 2009 UK awards for Allied Health Professionals and Healthcare Scientists
"Dr Till is an exceptional allergist clinician, research specialist and colleague. Stephen has designed number clinical trials with clear translational benefit for adult patients with both nut allergies and challenging rhinoconjunctivitis. He has held numerous roles nationally with the British Society of Clinical Allergy and Immunology as well as on the international stage at EAACI in recognition of his important research contribution. As a colleague, Stephen is highly expert and considered in his approach, and takes great care in looking after his patients. I would wholeheartedly recommend his expertise and support."